InflaRx N.V.(IFRX)

Biotech company with an oral drug for Hidradenitis Suppurativa

4 Insights

Investment Insights

AI-generated insights about InflaRx N.V. from various financial sources

Tuesday, November 18, 2025

Very Bearish

The speaker expresses extreme regret over buying the stock, calling it a 'fucking dog' and using it as an example of a position that should be sold to cut losses.

Martin Shkreli
11/18/25 +489%
Martin ShkreliYouTube171 days ago

Wednesday, November 12, 2025

Very Bullish

The speaker is long the stock and bullish on its prospects, mentioning it was one of his 'tons of different positions'.

Martin Shkreli
11/12/25 +516%
Martin ShkreliYouTube178 days ago

Monday, November 10, 2025

Very Bearish

The speaker holds a losing position, refers to the stock as 'shit' and 'dog poopoo', is down over 20%, and expresses regret over the trade. He is not adding to the position, using it as an example of a loser to let go.

Very Bullish

The speaker is long, viewing the stock as "pretty cheap" with a promising drug in a large market, but notes it's a long-term hold that could require sitting on for a year.

Martin Shkreli
11/10/25 +343%
Martin ShkreliYouTube180 days ago